Clinical trial
Dalbavancin in Real Clinical Practice in Spain: a Two-year Retrospective Study
NCT04485676 is registered in ClinicalTrials.gov with Angelini Farmacéutica as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dalbavancin in Real Clinical Practice in Spain: a Two-year Retrospective Study
- Lead sponsor
- Angelini Farmacéutica
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 15, 2020
- Completion date
- February 21, 2021
- Enrollment
- 187 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.